This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Opsona Therapeutics Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovations of Dominique De Kleijn
Introduction
Dominique De Kleijn is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of medical science, particularly in the treatment of ischemia reperfusion injury. His work focuses on developing compounds that can effectively address tissue damage caused by this condition.
Latest Patents
Dominique De Kleijn holds 1 patent for his invention titled "Composition and method for treatment of reperfusion injury and tissue damage." This patent presents compounds and methods aimed at treating and preventing ischemia reperfusion injury. The invention specifically provides compounds that function to suppress Toll-like Receptor 2 biological function or expression, showcasing his innovative approach to medical treatment.
Career Highlights
Throughout his career, Dominique has been associated with Opsona Therapeutics Limited, where he has been instrumental in advancing research and development in therapeutic solutions. His expertise in the field has positioned him as a key figure in the company, contributing to its mission of improving patient outcomes through innovative treatments.
Collaborations
Dominique has collaborated with several professionals in his field, including Brian Keogh and Christopher Phillip Locher. These collaborations have further enhanced his research and development efforts, leading to advancements in medical therapies.
Conclusion
Dominique De Kleijn's work exemplifies the impact of innovation in the medical field. His dedication to developing effective treatments for ischemia reperfusion injury highlights the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile